Eurolab is the only oncology company in Southern Africa to take a ‘whole-of-cancer’ approach - from diagnosis through treatment. It is our responsibility to make the best and latest treatments and technologies available and affordable for cancer patients. The Eurolab ASU is South Africa's first and only Aseptic Services Unit (ASU) of its kind, built to the latest manufacturing GMP (Good Manufacturing Practice) requirements (in line with the PIC/S standards). PIC is used to describe Pharmaceutical Inspection Convention (PIC) and the Pharmaceutical Inspection Co-Operation Scheme (PIC/S). To date the industry has relied solely on compounding pharmacies for admixing cytotoxics as the only enterprise legally authorised to perform this function. The ASU’s cutting-edge technology is a true game-changer in the ways it will significantly improve and enhance the accuracy, safety, quality, sterility and affordability of treatment for patients. Located in Midrand, the Eurolab ASU is completely purpose-built, and will be operational in early 2018. It provides a complete range of aseptic manufacturing services including patient-specific and later grouped batch chemotherapy will be made available - mixing both originator and generic products.
For more information, or to arrange a tour of the facility, please contact Robert Verseput, CEO of Eurolab ASU robert@eurolab.co.za

© Eurolab 2017   I   T: +27 (0)11 656 0031   I   info@eurolab.co.za       I      disclaimer

 

Eurolab is the largest generic oncology company in South Africa and the most innovative oncology company in all aspects of cancer treatment, therapies and technologies.

Eurolab is the only oncology company in Southern Africa to take a ‘whole-of-cancer’ approach - from diagnosis through treatment. It is our responsibility to make the best and latest treatments and technologies available and affordable for cancer patients. The Eurolab ASU is South Africa's first and only Aseptic Services Unit (ASU) of its kind, built to the latest manufacturing GMP (Good Manufacturing Practice) requirements (in line with the PIC/S standards). PIC is used to describe Pharmaceutical Inspection Convention (PIC) and the Pharmaceutical Inspection Co-Operation Scheme (PIC/S). To date the industry has relied solely on compounding pharmacies for admixing cytotoxics as the only enterprise legally authorised to perform this function. The ASU’s cutting-edge technology is a true game-changer in the ways it will significantly improve and enhance the accuracy, safety, quality, sterility and affordability of treatment for patients. Located in Midrand, the Eurolab ASU is completely purpose-built, and will be operational in early 2018. It provides a complete range of aseptic manufacturing services including patient-specific and later grouped batch chemotherapy will be made available - mixing both originator and generic products. For more information, or to arrange a tour of the facility, please contact Robert Verseput, CEO of Eurolab ASU robert@eurolab.co.za
Eurolab is the only oncology company in Southern Africa to take a ‘whole-of-cancer’ approach - from diagnosis through treatment. It is our responsibility to make the best and latest treatments and technologies available and affordable for cancer patients. The Eurolab ASU is South Africa's first and only Aseptic Services Unit (ASU) of its kind, built to the latest manufacturing GMP (Good Manufacturing Practice) requirements (in line with the PIC/S standards). PIC is used to describe Pharmaceutical Inspection Convention (PIC) and the Pharmaceutical Inspection Co-Operation Scheme (PIC/S). To date the industry has relied solely on compounding pharmacies for admixing cytotoxics as the only enterprise legally authorised to perform this function. The ASU’s cutting-edge technology is a true game-changer in the ways it will significantly improve and enhance the accuracy, safety, quality, sterility and affordability of treatment for patients. Located in Midrand, the Eurolab ASU is completely purpose-built, and will be operational in early 2018. It provides a complete range of aseptic manufacturing services including patient-specific and later grouped batch chemotherapy will be made available - mixing both originator and generic products. For more information, or to arrange a tour of the facility, please contact Robert Verseput, CEO of Eurolab ASU robert@eurolab.co.za
Eurolab is the only oncology company in Southern Africa to take a ‘whole-of-cancer’ approach - from diagnosis through treatment. It is our responsibility to make the best and latest treatments and technologies available and affordable for cancer patients. The Eurolab ASU is South Africa's first and only Aseptic Services Unit (ASU) of its kind, built to the latest manufacturing GMP (Good Manufacturing Practice) requirements (in line with the PIC/S standards). PIC is used to describe Pharmaceutical Inspection Convention (PIC) and the Pharmaceutical Inspection Co-Operation Scheme (PIC/S). To date the industry has relied solely on compounding pharmacies for admixing cytotoxics as the only enterprise legally authorised to perform this function. The ASU’s cutting-edge technology is a true game-changer in the ways it will significantly improve and enhance the accuracy, safety, quality, sterility and affordability of treatment for patients. Located in Midrand, the Eurolab ASU is completely purpose-built, and will be operational in early 2018. It provides a complete range of aseptic manufacturing services including patient-specific and later grouped batch chemotherapy will be made available - mixing both originator and generic products. For more information, or to arrange a tour of the facility, please contact Robert Verseput, CEO of Eurolab ASU robert@eurolab.co.za